Overview

Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis

Status:
Completed
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare subcutaneous Abatacept to placebo in the treatment of psoriatic arthritis
Phase:
Phase 3
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Abatacept